The NFL is teaming up with Canadian researchers to delve into the potential of cannabidiol (CBD) for pain management and neuroprotection from concussions, both significant concerns for its players. This Phase 1 trial marks a first step in exploring the non-intoxicating cannabinoid's therapeutic potential.
35 participants will test the safety and efficacy of CBD by receiving either a placebo or a cannabis extract enriched with the CBD compound, reported Cannabis Wire. Starting with a low dose of 5mg per kilogram of body weight, researchers from the University of Regina will gradually increase the amount to gauge optimal daily intake.
The study specifically aims to determine whether CBD, with its anti-inflammatory and neuroprotective properties, ...